Panagora Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,972
Closed -$208K 1289
2023
Q2
$208K Sell
9,972
-58
-0.6% -$1.26K ﹤0.01% 1190
2023
Q1
$236K Sell
10,030
-40,782
-80% -$1.1M ﹤0.01% 1323
2022
Q4
$1.42M Sell
50,812
-24,856
-33% -$636K 0.01% 749
2022
Q3
$1.77M Buy
75,668
+37,216
+97% +$1.12M 0.01% 641
2022
Q2
$1.3M Sell
38,452
-1,143
-3% -$40K 0.01% 774
2022
Q1
$1.38M Buy
39,595
+19,352
+96% +$662K 0.01% 807
2021
Q4
$616K Buy
20,243
+4,103
+25% +$134K ﹤0.01% 1124
2021
Q3
$529K Sell
16,140
-14,530
-47% -$465K ﹤0.01% 1290
2021
Q2
$928K Buy
+30,670
New +$1.01M 0.01% 1030

Other funds holding OGN

Panagora Asset Management's OGN Position: Q3 2023 in Review

Panagora Asset Management sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 9,972 shares — an estimated $208K sold.

Panagora Asset Management first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $1.77M in Q3 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Panagora Asset Management reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Panagora Asset Management sold 9,972 Organon & Co shares in Q3 2023, an estimated $208K.
  • Panagora Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Panagora Asset Management's Organon & Co position peaked at $1.77M in Q3 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Panagora Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.